This commonly prescribed cancer drug was supposed to help save his life. Instead, it killed him
After being diagnosed with colon cancer earlier this year, Dr. Anil Kapoor of Ontario was prescribed the common chemotherapy medication Fluorouracil. Three weeks later, he died from a toxic reaction to it. His brothers are on a mission to uncover who is most at risk and what the Canadian health-care system should do about it. (Source: CBC | Health)
Source: CBC | Health - November 27, 2023 Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news
This commonly prescribed cancer drug was supposed to help save this doctor's life. Instead, it killed him
After being diagnosed with colon cancer earlier this year, Dr. Anil Kapoor of Ontario was prescribed the common chemotherapy medication Fluorouracil. Three weeks later, he died from a toxic reaction to it. His brothers are on a mission to uncover who is most at risk and what the Canadian health-care system should do about it. (Source: CBC | Health)
Source: CBC | Health - November 27, 2023 Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news
Elastography predicts treatment response in colorectal cancer patients
Elastography could help with treatment strategies for colorectal cancer patients, a study presented November 26 at the RSNA annual meeting found.
In his presentation, Jae Seok Bae, MD, from Seoul National University Hospital in South Korea presented research that found that shear-wave velocity values measured after chemotherapy showed predictive performance in chemotherapy responsiveness in patients with colorectal cancer liver metastases.Jae Seok Bae, MD, from Seoul National University Hospital presented research at RSNA showing the efficacy of shear-wave elastography in predicting chemotherapy response in colorectal pat...
Source: AuntMinnie.com Headlines - November 26, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: Resources Ultrasound Genitourinary Radiology Conference RSNA 2023 Source Type: news
Chemoimmunotherapy Improves Pathologic Outcomes in Gastroesophageal Carcinoma
(MedPage Today) -- Adding immunotherapy to neoadjuvant chemotherapy for resectable gastroesophageal cancer led to higher rates of disease downstaging and pathologic complete response (pCR), an exploratory analysis of a randomized trial showed... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - November 24, 2023 Category: Gastroenterology Source Type: news
FDA Approves Ryzneuta (efbemalenograstim alfa) for Chemotherapy-Induced Neutropenia
November 22, 2023, New Jersey– Evive Biotech (Evive), a global biopharmaceutical company devoted to developing novel biologic therapies and a subsidiary of Yifan Pharmaceutical Co. Ltd., and Acrotech Biopharma (Acrotech), a New Jersey-based... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 22, 2023 Category: Drugs & Pharmacology Source Type: news
FAPI-PET shows promise for detecting pancreatic cancer
In this study, the researchers analyzed data on 62 patients with suspected pancreatic cancer. In addition to Ga-68 FAPI-PET imaging, all patients also underwent contrast-enhanced CT, and 38 underwent F-18 FDG-PET. The primary endpoint was the association between Ga-FAPI-PET radiotracer maximum standardized uptake value (SUVmax) and histopathologic FAP expression, while secondary endpoints included comparisons to standard imaging.A male patient with suspected recurrent pancreatic cancer. Contrast-enhanced CT shows mass around superior mesenteric artery after pancreatectomy. F-18 FDG only shows discrete uptake of lesion (SU...
Source: AuntMinnie.com Headlines - November 20, 2023 Category: Radiology Authors: Will Morton Tags: Nuclear Radiology Source Type: news
FDA OKs First-Line Pembro With Chemo for Gastric/GEJ Cancer FDA OKs First-Line Pembro With Chemo for Gastric/GEJ Cancer
Adding pembrolizumab to chemotherapy had significant benefits in patients with locally advanced unresectable or metastatic, HER2-negative gastric or gastroesophageal junction adenocarcinoma.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 17, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
Hospitals serving large Black, Latino populations have fewer resources for cancer care
Key takeawaysUCLA researchers looked at nearly 4,400 hospitals across the U.S., including 864 with high numbers of Black and Hispanic patients.Hospitals serving Black, Hispanic and other racial and ethnic minority patients were significantly less likely than other hospitals to have access to core cancer services like PET/CT scanners, robotic surgery and palliative care.The researchers say further work is need to understand how geographic, linguistic, cultural, cost and discrimination factors affect these cancer care disparities. Among the nation ’s hospitals, those that serve high numbers of Black and Hispanic patients...
Source: UCLA Newsroom: Health Sciences - November 16, 2023 Category: Universities & Medical Training Source Type: news
FDA Approves Merck ’s Keytruda (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Locally Advanced Unresectable or Metastatic HER2-Negative Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Approval based on results from the Phase 3 KEYNOTE-859 trial, which demonstrated significant improvement in overall survival in these patients versus chemotherapy alone
Approval marks seventh gastrointestinal cancer indication for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 16, 2023 Category: Drugs & Pharmacology Source Type: news
FDA approves pembrolizumab with chemotherapy for HER2-negative gastric or gastroesophageal junction adenocarcinoma
On November 16, 2023, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of adults with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 16, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Osimertinib + Chemo Improves Progression-Free Survival in Advanced NSCLC
THURSDAY, Nov. 16, 2023 -- For patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), osimertinib with chemotherapy leads to significantly longer progression-free survival (PFS) compared with osimertinib alone, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2023 Category: Pharmaceuticals Source Type: news
CRISPR Therapy Gets U.K. Approval, the First in the World
Britain’s medicines regulator has authorized the world’s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K.
[time-brightcove not-tgx=”true”]
In a statement on Thursday, the Medicines and Healthcare Regulatory Agency said it approved Casgevy, the first medicine licensed using the gene editing tool CRISPR, which won its makers a Nobel prize in 2020.
The agency approved the treatment for patients with sickle cell disease and thalassemia who are 12 years old and over. Casgevy is made by Vertex ...
Source: TIME: Health - November 16, 2023 Category: Consumer Health News Authors: MARIA CHENG / AP Tags: Uncategorized Drugs wire Source Type: news
Pembrolizumab + Standard Chemotherapy Beneficial in Mesothelioma
WEDNESDAY, Nov. 15, 2023 -- The addition of pembrolizumab to standard platinum-pemetrexed chemotherapy results in significant improvement in overall survival among patients with advanced pleural mesothelioma, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 15, 2023 Category: Pharmaceuticals Source Type: news
CIPN Tied to Compromised Executive and Neuromuscular Function CIPN Tied to Compromised Executive and Neuromuscular Function
Chemotherapy-induced peripheral neuropathy is linked to a decline in executive and neuromuscular function, new findings that may compromise mobility and increase fall risk.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 14, 2023 Category: Cancer & Oncology Tags: Neurology & Neurosurgery News Source Type: news
Road to RSNA 2023: Ultrasound
Ultrasound's utility will be on full display at this year's RSNA annual meeting, showing its merit in a wide variety of clinical applications. Research to be presented at the annual meeting in Chicago will explore the modality's clinical applications in musculoskeletal, pediatric, abdominal, and women's imaging among other areas. This includes advancements in ultrasound in recent years, such as the use of contrast for improved imaging, elastography and color Doppler for assessing complex pathologies, and using imaging data in AI models. Studies will also evaluate ways to further improve the modality's capabilities by rea...
Source: AuntMinnie.com Headlines - November 14, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: 2023 2023 Ultrasound Preview Source Type: news
